NDC product
TABLET · Takeda Pharmaceutical Company LTD
NDC 11532-0022 · Takeda Pharmaceutical Company LTD
Key facts
| Product NDC | 11532-0022 |
|---|---|
| Nonproprietary name | pioglitazone hydrochloride and metformin hydrochloride |
| Substances | PIOGLITAZONE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE |
| Dosage form | TABLET |
| Labeler | Takeda Pharmaceutical Company LTD |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Aug 29, 2005 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: